CN107011481A - A kind of preparation method of endotoxin absorbent - Google Patents
A kind of preparation method of endotoxin absorbent Download PDFInfo
- Publication number
- CN107011481A CN107011481A CN201610057333.7A CN201610057333A CN107011481A CN 107011481 A CN107011481 A CN 107011481A CN 201610057333 A CN201610057333 A CN 201610057333A CN 107011481 A CN107011481 A CN 107011481A
- Authority
- CN
- China
- Prior art keywords
- preparation
- resin
- reaction
- epoxy resin
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/32—Esters containing oxygen in addition to the carboxy oxygen containing epoxy radicals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/262—Synthetic macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. obtained by polycondensation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28004—Sorbent size or size distribution, e.g. particle size
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28016—Particle form
- B01J20/28021—Hollow particles, e.g. hollow spheres, microspheres or cenospheres
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/12—Polymerisation in non-solvents
- C08F2/16—Aqueous medium
- C08F2/20—Aqueous medium with the aid of macromolecular dispersing agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
- C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/32—Esters containing oxygen in addition to the carboxy oxygen containing epoxy radicals
- C08F220/325—Esters containing oxygen in addition to the carboxy oxygen containing epoxy radicals containing glycidyl radical, e.g. glycidyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2810/00—Chemical modification of a polymer
- C08F2810/50—Chemical modification of a polymer wherein the polymer is a copolymer and the modification is taking place only on one or more of the monomers present in minority
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- External Artificial Organs (AREA)
Abstract
Present invention relates particularly to a kind of preparation method of endotoxin absorbent, wherein endotoxin absorbent includes being bonded the histidine ligand in carrier surface as the porous epoxy resin and chemical covalent of carrier.The present invention is to prepare porous epoxy resin of the particle diameter at 100 μm -500 μm using suspension polymerization, mixed again with anhydrous ethylenediamine with epoxy resin, heating stirring obtains amine resin, amine resin and glutaraldehyde hybrid reaction are then obtained formaldehyde-based resin, finally endotoxin absorbent is obtained with histidine ligand reaction.
Description
Technical field
The invention belongs to field of polymer technology, and in particular to a kind of preparation method of endotoxin absorbent.
Background technology
Endotoxemia is due to that endotoxin on the outer cell membrane of Gram-negative bacteria is discharged into blood and caused
, it may occur in which in a variety of lysises, such as large-area burns, serious hepatitis, hepatic sclerosis disease,
Body's immunity is badly damaged, and shock, disseminated intravascular coagulation, multiple organ dysfunction can be caused
A series of serious pathological changes such as exhaustion, ultimately result in organ necrosis, irreversible shock and death, face
Effective treatment method is there is no on bed.How to accomplish in time, effectively to remove or destroy interior in patient's body
Toxin, is the key issue for treating endotoxemia.Abroad in Recent Years have developed a variety of anti-endotoxins
Molecular biosciences preparation, but complex manufacturing, medicine source due to antibody is few, cost is high, and price is very high
It is expensive, and there is no one kind can be by III phase clinical trials so far.
To some great difficult and complicated illness, blood purification therapy has unique curative effect, is that clinical treatment is indispensable
Important means, wherein blood perfusion therapy be by adsorbent directly adsorb remove blood in it is poisonous into
Part or morbid substance, reach purification blood, alleviate and treat the purpose of disease.Domestic and international researcher has been opened
The method treatment endotoxemia of beginning research and utilization blood purification, discovery has certain effect.Wherein use
It is to remove a kind of endotoxic very promising method that endotoxin absorbent, which carries out blood purification therapy,.Endogenous toxic material
Plain adsorbent is from specific absorption part, energy selective absorption endotoxin.The affinity ligand reported
How adhesive rhzomorph B, histidine, polycation part, deoxycholic acid etc., part mainly by ionic bond and
Hydrophobic effect is combined with endotoxin, reaches the endotoxic purpose of removal.
The content of the invention
It is an object of the invention to provide a kind of new endotoxin absorbent and preparation method thereof, the endotoxin is inhaled
Attached dose uses the epoxy high score that Inorganic whisker thing prestox acrylate POSS is that crosslinking agent is prepared from
Son is carrier, and the histidine that selection induced by endotoxin has higher recognition capability and adsorption capacity is inhaled as endotoxin
Attached part, is removed available for endotoxic in biochemical product and blood.
The technology path of the present invention is to use suspension polymerization using GMA as monomer, eight
Methacrylate POSS be crosslinking agent, prepared in the presence of pore-foaming agent particle diameter 100 μm-
The porous resin polymer microsphere of 500 μ ms.Reacted with the epoxide group on anhydrous ethylenediamine and resin
Introduce amino.Then the resin with aldehyde radical is obtained with glutaraldehyde with the resin reaction with amino.Finally
The histidine aqueous solution and mixed with resin react obtaining endotoxin absorbent.
Specifically include following content:
(1) preparation of porous epoxy resin
The aqueous solution containing dispersant is prepared, by GMA, prestox acrylate
POSS, initiator and pore-foaming agent miscella are added in the aqueous solution, and heating stirring obtains porous microsphere tree
Fat.
(2) prepared by formaldehyde-based resin
Mixed first with anhydrous ethylenediamine with epoxy resin, heating stirring obtains amine resin, then amine
Base resin is mixed with glutaraldehyde solution, prepares formaldehyde-based resin.
(3) preparation of endotoxin absorbent
Endotoxin absorbent is obtained with the histidine aqueous solution and formaldehyde-based resin reaction.
Initiator described in above-mentioned reaction is benzoyl peroxide, and initiator is relative to monomer (metering system
Acid glycidyl ester) mass percent be 0.5-10%.
The pore-foaming agent can select toluene, ethylbenzene, n-hexane, normal heptane, normal octane, n-amyl alcohol, neighbour
Between one or two or more kinds of pore-foaming agents in Phthalates different volumes than mixture, pore-foaming agent
Mass percent relative to monomer is listed in 50-200%.
The dispersant is polyvinyl alcohol and gelatin, mass ratio row 1 between the two:1-6, dispersant and water
Mass percent be classified as 0.4-8%.
Step (1) described heating stirring is generally in 150-400r.p.m., and reaction temperature is generally at 70-80 DEG C.
The reaction of step (2) anhydrous ethylenediamine and epoxy resin is carried out in a heated condition, both it
Between the ratio between mass number be 1-5:1.
The temperature of described aminated reaction is 60-90 DEG C, and the reaction time is 2-20 hours, and aldehyde radicalization is anti-
The temperature answered is 30-50 DEG C, and the reaction time is 2-20 hours.
The ratio between mass number of glutaraldehyde and epoxy resin is 1-5:1;
The mass concentration of step (3) histidine aqueous solution is 0.5-10%, histidine and formaldehyde-based resin matter
It is 1-5 to measure the ratio between number:100, reaction temperature is 40 DEG C, and the reaction time is 2-20 hours.
Advantages of the present invention is:Using the histidine without endogenous toxicity as part, mild reaction conditions are utilized
The reaction of aldehyde amine has synthesized endotoxin adsorption material.
Embodiment
Embodiment 1
(1) preparation of porous epoxy resin
The aqueous solution 1L that it is 10g/L containing polyvinyl alcohol to prepare and gelatin is 20g/L is as suspension polymerisation
Method prepares the aqueous phase solution of epoxy resin reaction system.120mg benzoyl peroxides are dissolved in containing 12mL
GMA, 2g prestox acrylate POSS and 18mL n-amyl alcohols mixing it is molten
In liquid, the oiliness mixed solution is added in 60mL aqueous phase solutions, obtained water-oil phase layering
Mixed system under 300r.p.m. mechanical agitation speed at room temperature to stir 1 hour, then by temperature
80 DEG C are increased to, polymerisation 20 hours, obtained product epoxy resin is washed with acetone and ethanol successively
Three times standby after being dried in vacuo 12 hours at 60 DEG C.
(2) prepared by formaldehyde-based resin
100mL ethylenediamines are added in 10g epoxy resin, is reacted 5 hours at 80 DEG C, obtains amine
Base resin, is then mixed with the 100mL glutaraldehyde water solution of mass concentration 50% again, in 40 DEG C of stirrings
Reaction obtains formaldehyde-based resin in 10 hours.
(3) preparation of endotoxin absorbent
Mass concentration is that 1% histidine aqueous solution 100mL is mixed with 30g formaldehyde-based resins, at 40 DEG C
Reaction 8 hours, obtained product with water and ethanol with washing three times after being dried in vacuo 12 at 60 DEG C successively
It is standby after hour.
Prepared adsorbent is endotoxin removal rate in 12Eu/mL endotoxin solution to 1mL concentration
For 89.6%.
Embodiment 2
(1) preparation of porous epoxy resin
The aqueous solution 1L that it is 8g/L containing polyvinyl alcohol to prepare and gelatin is 12g/L is as suspension polymerization
Prepare the aqueous phase solution of epoxy resin reaction system.200mg benzoyl peroxides are dissolved in containing 10mL
The mixed solution of GMA, 5g prestox acrylate POSS and 20mL n-hexanes
In, the oiliness mixed solution is added in the 60mL aqueous solution, the mixing of obtained water-oil phase layering
System to be stirred 1 hour under 300r.p.m. mechanical agitation speed, then raises temperature at room temperature
To 80 DEG C, polymerisation 20 hours, obtained product epoxy resin is washed three times with acetone and ethanol successively
It is standby after being dried in vacuo 12 hours at 60 DEG C.
(2) preparation of formaldehyde-based resin
100mL ethylenediamines are added in 10g epoxy resin, is reacted 5 hours at 80 DEG C, obtains amine
Base resin, is then mixed with the 100mL glutaraldehyde water solution of mass concentration 50% again, in 45 DEG C of stirrings
Reaction obtains formaldehyde-based resin in 10 hours.
(3) preparation of endotoxin absorbent
Mass concentration is that 1% histidine aqueous solution 100mL is mixed with 30g formaldehyde-based resins, anti-at 45 DEG C
Answer 8 hours, obtained product is small after vacuum drying 12 at 60 DEG C with washing three times with water and ethanol successively
Shi Houbei is used.
Prepared adsorbent is endotoxin removal rate in 12Eu/mL endotoxin solution to 1mL concentration
For 93.4%.
Claims (7)
1. a kind of preparation method of endotoxin absorbent, it is characterised in that:Used in the endotoxin absorbent
Carrier is polymer microsphere;
Suspension polymerization is used using GMA as monomer, prestox acrylate POSS
For crosslinking agent, porous epoxy resin polymer microsphere is prepared in the presence of pore-foaming agent;Use anhydrous second
Diamines introduces amino with the epoxide group reaction on resin;It is then anti-with glutaraldehyde and the resin with amino
The resin with aldehyde radical should be obtained;Finally the histidine aqueous solution and the mixed with resin with aldehyde radical are carried out anti-
Endotoxin absorbent should be obtained.
2. according to the preparation method described in claim 1, it is characterised in that:Using suspension polymerisation legal system
Porous epoxy resin polymer microsphere of the standby particle diameter in 100 μm of -500 μ m.
3. according to the preparation method described in claim 1, it is characterised in that:
Detailed process is as follows:
(1) preparation of porous epoxy resin:
The aqueous solution containing dispersant is prepared, by GMA, prestox acrylate
POSS, initiator and pore-foaming agent miscella are added in the aqueous solution, and heating stirring obtains porous microsphere tree
Fat;
(2) prepared by formaldehyde-based resin:
Mixed first with ethylenediamine with epoxy resin, heating stirring obtains amine resin, then amido tree
Fat is mixed with glutaraldehyde solution, prepares formaldehyde-based resin;
(3) preparation of endotoxin absorbent:
Endotoxin absorbent is obtained with the histidine aqueous solution and formaldehyde-based resin reaction.
4. according to the preparation method described in claim 3, it is characterised in that:
Initiator described in above-mentioned reaction is benzoyl peroxide, quality percentage of the initiator relative to monomer
Number is 0.5-10%;
The pore-foaming agent can select toluene, ethylbenzene, n-hexane, normal heptane, normal octane, n-amyl alcohol, neighbour
One or two or more kinds in Phthalates, pore-foaming agent is listed in relative to the mass percent of monomer
50-200%;
The dispersant is polyvinyl alcohol and gelatin, mass percent row 1 between the two:1-6, disperses
The mass percent of agent and water is classified as 0.4-8%.
5. according to the preparation method described in claim 3, it is characterised in that:
Step (1) described heating stirring is generally in 150-400r.p.m., and reaction temperature generally exists
70-80℃。
6. according to the preparation method described in claim 3, it is characterised in that:
The reaction of step (2) ethylenediamine and epoxy resin is carried out in a heated condition, between the two
The ratio between mass number be 1-5:1;
The temperature of described aminated reaction is 60-90 DEG C, and the reaction time is 2-20 hours, and aldehyde radicalization is anti-
The temperature answered is 30-50 DEG C, when the reaction time is 2-20;
The ratio between mass number of glutaraldehyde and epoxy resin is 1-5:1.
7. according to the preparation method described in claim 3, it is characterised in that:
The mass concentration of step (3) histidine aqueous solution is 0.5-10%, histidine and formaldehyde-based resin matter
It is 1-5 to measure the ratio between number:100, reaction temperature is 40 DEG C, and the reaction time is 2-20 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610057333.7A CN107011481B (en) | 2016-01-27 | 2016-01-27 | A kind of preparation method of endotoxin absorbent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610057333.7A CN107011481B (en) | 2016-01-27 | 2016-01-27 | A kind of preparation method of endotoxin absorbent |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107011481A true CN107011481A (en) | 2017-08-04 |
CN107011481B CN107011481B (en) | 2018-11-02 |
Family
ID=59438578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610057333.7A Active CN107011481B (en) | 2016-01-27 | 2016-01-27 | A kind of preparation method of endotoxin absorbent |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107011481B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112755973A (en) * | 2020-12-16 | 2021-05-07 | 重庆天外天生物技术有限公司 | Composite adsorption material applied to blood purification field and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1194179A (en) * | 1997-03-26 | 1998-09-30 | 中国科学院大连化学物理研究所 | Chemical modification of microporous nylon film and preparation of affinity film with histidine ligand |
WO2005026224A1 (en) * | 2003-09-17 | 2005-03-24 | Gambro Lundia Ab | Separating material |
US20120123002A1 (en) * | 2009-07-03 | 2012-05-17 | Asahi Kasei Medical Co., Ltd. | Method for purification of antibody using porous membrane having amino group and alkyl group both bound to graft chain immobilized on porous substrate |
-
2016
- 2016-01-27 CN CN201610057333.7A patent/CN107011481B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1194179A (en) * | 1997-03-26 | 1998-09-30 | 中国科学院大连化学物理研究所 | Chemical modification of microporous nylon film and preparation of affinity film with histidine ligand |
WO2005026224A1 (en) * | 2003-09-17 | 2005-03-24 | Gambro Lundia Ab | Separating material |
US20120123002A1 (en) * | 2009-07-03 | 2012-05-17 | Asahi Kasei Medical Co., Ltd. | Method for purification of antibody using porous membrane having amino group and alkyl group both bound to graft chain immobilized on porous substrate |
Non-Patent Citations (1)
Title |
---|
商振华等: ""去除内毒素的柱亲和介质与膜亲和介质的制备和特征"", 《分析化学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112755973A (en) * | 2020-12-16 | 2021-05-07 | 重庆天外天生物技术有限公司 | Composite adsorption material applied to blood purification field and preparation method thereof |
CN112755973B (en) * | 2020-12-16 | 2023-03-10 | 重庆天外天生物技术有限公司 | Composite adsorption material applied to blood purification field and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN107011481B (en) | 2018-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7033083B2 (en) | Use of blood-compatible porous polymer bead sorbent to remove endotoxin-inducing molecules | |
CN104525151B (en) | Endotoxin absorbent for hemoperfusion and preparation method thereof | |
CN104394964B (en) | With reference to globule and the filter for installation of fiber | |
Cao et al. | Polymyxin B immobilized on cross-linked cellulose microspheres for endotoxin adsorption | |
US20120108794A1 (en) | Formyl Group-Containing Porous Support, Adsorbent Using Same, Method For Producing Same, and Method For Producing The Adsorbent | |
CN105709705A (en) | Molecular imprinting adsorbent for eliminating blood bilirubin and preparation method thereof | |
CN107899066A (en) | Cation polyhydroxylated polymer embolism microball and preparation method thereof | |
CN112090410A (en) | Blood purification adsorbent with interpenetrating network coating, preparation method and perfusion apparatus | |
CN106140110B (en) | A kind of preparation method of low-density lipoprotein adsorbent | |
CN107011481A (en) | A kind of preparation method of endotoxin absorbent | |
CN102977275A (en) | Use of phosphorylcholine groups for improving biocompatibility of adsorption resin | |
Iacob et al. | Metal–Ligand Interactions in Molecular Imprinting | |
JP5467986B2 (en) | Polymer substrate for removing botulinum toxin and medical device | |
CN109248668B (en) | Adsorbent for removing LDL (low-density lipoprotein) by blood extracorporeal circulation, preparation method thereof and perfusion apparatus | |
CN102580683B (en) | Endotoxin synergistic adsorbent and preparation method thereof | |
CN103301446B (en) | Affinity adsorption material for treating hyperbilirubinemia and preparation method thereof | |
CN107406824A (en) | The method of purifying biological composition and the product for it | |
CN105688841B (en) | A kind of immuno absorbence polymer microsphere and its preparation and application | |
CN107011480B (en) | Adsorbent for bilirubin preparation method of the amino acid as ligand | |
CN109384875A (en) | A kind of preparation method of polyacrylic resin | |
CN112126638B (en) | Lipase immobilized resin and preparation method thereof | |
JPH06233816A (en) | Hemocatharsis adsorbent | |
JPH06237995A (en) | Blood purifying/adsorbing material | |
JPH06237996A (en) | Blood purifying/adsorbing material | |
JP4228498B2 (en) | Heparin adsorbent and method for removing heparin using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |